StreetInsider.com News Articles

Form 4 Ainos, Inc. For: Jun 05 Filed by: chiang yao-chung

Tue, 09 Jun 2026 12:05:00 -0400

si-local-file:///var/storage/secattach/20260609/26622583.html

Form 4 Ainos, Inc. For: Jun 05 Filed by: chiang yao-chung

Tue, 09 Jun 2026 12:05:00 -0400

si-local-file:///var/storage/secattach/20260609/26622583.html

Ainos reports 499% revenue growth in 2025, expands AI scent technology

Mon, 08 Jun 2026 08:00:11 -0400

Ainos Inc. (NASDAQ: AIMD) released its 2026 mid-year shareholder letter, reporting 499% year-over-year revenue growth during fiscal year 2025. The company has shifted from biotechnology focus to technology platform development centered on artificial intelligence-powered scent digitization.

The Houston-based company advanced commercial deployments in semiconductor manufacturing environments during the first half of 2026. Ainos collaborated with advanced semiconductor manufacturers and strategic industry partners to expand industrial-scale scent AI datasets for environmental intelligence and safety monitoring applications.

The company expanded its scent AI technology into healthcare settings through collaborative research programs with National Taiwan University Hospital and MacKay Memorial Hospital. These initiatives focus on

Ainos reports 499% revenue growth in 2025, expands AI scent technology

Mon, 08 Jun 2026 08:00:11 -0400

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

HOUSTON, TX / ACCESS Newswire / June 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today released its 2026 Mid-Year Letter to Shareholders from Chairman, President and Chief Executive Officer Eddy Tsai.

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Mon, 08 Jun 2026 08:00:00 -0400

Building the Olfactory Layer of Physical AI

Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications

2026 First Half Highlights

Commercial Momentum

Reported 499% year-over-year revenue growth during fiscal year 2025.
Continued transforming Ainos from a biotechnology-focused company into a technology platform company centered on Smell AI and Environmental Intelligence.
Updated the

Form 4 Ainos, Inc. For: Jun 03 Filed by: chiang yao-chung

Fri, 05 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26611120.html

Form 4 Ainos, Inc. For: Jun 03 Filed by: chiang yao-chung

Fri, 05 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260605/26611120.html

Ainos expands AI Nose platform into hospital emergency departments

Fri, 05 Jun 2026 08:02:52 -0400

Ainos Inc. (NASDAQ: AIMD) announced that research firm VASRO GmbH published a report discussing the company's expansion of its AI Nose platform into emergency department operations at an Asian academic medical center.

The research program deploys AI Nose technology within a live emergency department to evaluate environmental scent analysis for overcrowding early warning and respiratory infection risk analysis. The initiative is designed to generate more than 2,500 hours of emergency department environmental data.

According to the VASRO report, this deployment expands AI Nose beyond its current applications in semiconductor manufacturing, industrial environments, and robotics into healthcare infrastructure. The platform digitizes scent into

Ainos expands AI Nose platform into hospital emergency departments

Fri, 05 Jun 2026 08:02:52 -0400

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Fri, 05 Jun 2026 08:00:00 -0400

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a recent report published by VASRO GmbH ("VASRO"), discussing the expansion of the Company's AI Nose platform into emergency department operations and the continued growth of its Smell ID data across diverse real-world environments.

In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Fri, 05 Jun 2026 08:00:00 -0400

In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Fri, 05 Jun 2026 08:00:00 -0400

In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Fri, 05 Jun 2026 08:00:00 -0400

In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live

RedChip Showcases Public Companies Driving Technological Innovation at June 10 Virtual Investor Conference